These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16286748)

  • 1. Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case.
    Kasraee B; Handjani F; Parhizgar A; Omrani GR; Fallahi MR; Amini M; Nikbakhsh M; Tran C; Hügin A; Sorg O; Saurat JH
    Dermatology; 2005; 211(4):360-2. PubMed ID: 16286748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of topical methimazole for the treatment of melasma. Transdermal absorption, the effect on thyroid function and cutaneous adverse effects.
    Kasraee B; Safaee Ardekani GH; Parhizgar A; Handjani F; Omrani GR; Samani M; Nikbakhsh M; Tanideh N; Eshraghian A; Sorg O; Saurat JH
    Skin Pharmacol Physiol; 2008; 21(6):300-5. PubMed ID: 18667842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
    Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
    J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on doses of methimazole (MMI) and its administration regimen on broiler metabolism.
    Rosebrough RW; Russell BA; McMurtry JP
    Comp Biochem Physiol A Mol Integr Physiol; 2006 Jan; 143(1):35-41. PubMed ID: 16337159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroquinone-free multimodal topical regimen for facial hyperpigmentation.
    Foad MS; Winters E
    J Drugs Dermatol; 2013 Mar; 12(3):S42-4. PubMed ID: 23545933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The depigmenting effect of RALGA in C57BL/6 mice.
    Kasraee B; Tran C; Sorg O; Saurat JH
    Dermatology; 2005; 210 Suppl 1():30-4. PubMed ID: 15724105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by 2-iodohexadecanal.
    Thomasz L; Oglio R; Rivandeira DT; Dagrosa MA; Jahn G; Pignataro OP; Sartorio G; Pisarev MA; Juvenal GJ
    Mol Cell Endocrinol; 2010 Apr; 317(1-2):141-7. PubMed ID: 20036711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dosed antithyroid drug monotherapy in hyperthyroidism.
    Seidel C; Ziegelitz D; Frenzel R; Dittmer T
    Exp Clin Endocrinol; 1984 Mar; 83(1):73-86. PubMed ID: 6539216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
    J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimelanogenic activity of a novel adamantyl benzylbenzamide derivative, AP736: a randomized, double-blind, vehicle-controlled comparative clinical trial performed in patients with hyperpigmentation during the summer.
    Jeong YS; Kim JH; Choi J; Baek HS; Joo YH; Lee CS; Shin HJ; Park YH; Kim BJ; Shin SS
    Int J Dermatol; 2016 Jun; 55(6):e321-6. PubMed ID: 26712041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide.
    Bissett DL; Robinson LR; Raleigh PS; Miyamoto K; Hakozaki T; Li J; Kelm GR
    J Cosmet Dermatol; 2009 Dec; 8(4):260-6. PubMed ID: 19958429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
    Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
    J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and short-term clinicopathologic changes after intravenous administration of a high dose of methimazole in dogs.
    Vail DM; Elfarra AA; Panciera DL; Hutson PR
    Am J Vet Res; 1994 Nov; 55(11):1597-601. PubMed ID: 7879985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.